Photons vs. Protons: How to Choose the Right Radiotherapy for Cancer

"Doctor, I need radiotherapy. I heard there are photons and protons. Which one should I choose?" This is one of the most common questions we hear in the clinic. The confusion is completely understandable. At its core, the right choice depends on one question: for my tumor, which approach can deliver the strongest blow to the cancer while protecting the rest of my body as much as possible?

This guide is designed to help you understand the logic behind your doctor's recommendation — without drowning in jargon. Let's start by comparing the two main weapons.

Two Weapons: How Are They Different?

All radiotherapy uses radiation to destroy cancer cells. The fundamental goal is the same: kill the tumor while sparing healthy tissue. But radiation comes in different forms.

1. By Type of Radiation

Photon rays (including X-rays and gamma rays) are electromagnetic waves that pass through the body. They are the most established and widely used radiotherapy technology.

Particle rays (including proton and heavy-ion beams) are made of charged particles. They have a unique physical property: they release energy gently as they enter the body, then suddenly release a burst of energy at a precise depth inside the tumor. This is like a "depth charge" that sinks to the target before detonating.

2. By Delivery Method

External beam radiotherapy: The machine fires radiation from outside the body, like a long-range missile. Both photon and proton therapy fall into this category.

Internal radiotherapy (brachytherapy): A radioactive source is placed directly inside or next to the tumor, like a landmine. Examples include cervical cancer brachytherapy and prostate seed implants.

Among these options, the most common dilemma is whether to choose conventional photon radiotherapy or more precise proton therapy. Here is a simple analogy to understand the difference.

In short: The core advantage of proton therapy is that it can deliver the required tumor dose while better protecting the healthy organs around the tumor.

Four Questions to Make the Choice Clear

You don't need to make this decision alone. Use these four dimensions as a framework for your discussion with the oncology team.

Question 1: What Kind of Tumor Is It?

Some tumors are especially well-suited to proton therapy because of their location or sensitivity.

• Pediatric and adolescent tumors: Proton therapy can significantly reduce the impact on growth and lower the risk of second primary cancers. A 2025 study of 151 children showed cumulative rates of symptomatic brain necrosis and secondary intracranial tumors at 5 years were only 2.3% and 2.7%, respectively.
• Tumors next to critical organs: Tumors in the brain near the brainstem, optic nerves, or spinal cord require extreme precision. A small dose increase can cause blindness or paralysis. Proton therapy can control the tumor while protecting these functional "red lines."
• Radioresistant tumors: Skull base chordomas require very high doses to control. Proton therapy can deliver this high-dose precision strike and improve tumor control.

Question 2: Can the Body Tolerate It?

This refers to your tolerance for treatment side effects.

• Poor heart or lung function: For left-sided breast cancer, proton therapy can significantly reduce heart and lung radiation. A 2025 study showed that intensity-modulated proton therapy (IMPT) reduced mean heart dose by about 5.22 Gy and mean lung dose by about 9.88 Gy compared with photon VMAT.
• Young patients with low-grade glioma: Preserving cognitive function is critical. A 2025 phase II trial showed that the rate of new cognitive impairment after proton therapy was 26% at 5 years, and neuroendocrine dysfunction was only 5.3%.

Question 3: What Is the Treatment Goal?

• Curative intent: We want the most precise and sufficient dose to eradicate the tumor. Technologies that better protect normal tissue (such as proton therapy) are advantageous because they allow physicians to escalate the tumor dose with fewer complications.
• Palliative intent: When the goal is rapid relief of pain from bone metastases or to shrink a tumor compressing the airway, fast-acting and widely available technologies (such as conventional photon radiotherapy) are often the more practical choice.

Question 4: What Are the Real-World Conditions?

Three practical factors matter:

• Equipment availability: Proton therapy centers are still limited in number. Not every patient has convenient access.
• Economic cost: Although upfront costs are higher than traditional radiotherapy, proton therapy can be more cost-effective over the long term. It significantly reduces late side effects such as hearing loss and endocrine dysfunction, lowers the risk of second primary cancers, and avoids expensive rehabilitation later. More commercial insurance plans are also beginning to cover proton therapy.
• Time cost: From planning to treatment, proton therapy usually takes longer than conventional radiotherapy.

Proton Therapy at GCCC

As the first proton therapy center in clinical operation in South China, Guangzhou Concord Cancer Center is equipped with the world-class Varian ProBeam® proton therapy system. We follow MD Anderson Cancer Center radiotherapy protocols to provide individualized, precise treatment plans for patients with complex tumors.

Our proton therapy team has deep experience in treating pediatric tumors, skull base chordomas, prostate cancer, breast cancer, and other tumors where protecting surrounding organs is critical.

References

1. Indelicato DJ, et al. Late Outcomes of Pencil Beam Scanning Proton Therapy for Intracranial Tumors in Children and Adolescents. Int J Radiat Oncol Biol Phys. 2025;111(3):e45.
2. Hayden A, et al. Radiotherapy for treatment of skull base chordoma. Cochrane Database Syst Rev. 2025;3:CD013491.
3. Zhou P, et al. Effectiveness and Safety of Proton and Heavy Ion Therapy for Recurrent Skull Base Chordoma. J Craniofac Surg. 2025 Mar 19.
4. Qiu J, et al. Dosimetric Comparison of Intensity-Modulated Proton Therapy and Volumetric-Modulated Arc Therapy for Bilateral Breast Cancer. Int J Part Ther. 2025;15:100785.
5. Mast ME, et al. Left-sided breast cancer radiotherapy with and without breath-hold: Does IMRT reduce the cardiac dose even further? Radiother Oncol. 2013;108(2):248-53.
6. Sherman JC, et al. Prospective Phase II Trial of Proton Beam Therapy for Low-Grade Glioma: Late Effects on Cognitive Function and Neuroendocrinology. J Clin Oncol. 2025;43(1):45-55.
7. Vanderplas D, et al. Cognitive function in low-grade glioma patients considered for proton beam therapy. Neurooncol Pract. 2024;11(6):736-744.
8. Deseyn D, et al. Cost-Effectiveness of Proton Therapy for Breast Cancer in a Modern Radiation Oncology Landscape. Int J Part Ther. 2025;15:100801.